雾化吸入疗法急诊临床应用专家共识

2018-07-30 中国医师协会急诊医师分会 中国急救医学.2018.38(7):565-574.

为了规范雾化吸入疗法的临床应用,结合急诊急救专业的特殊性:①急症患者发病突然,疾病进展不可预见;②呼吸系统疾病占比高,有统计显示,我国因呼吸系统疾病急诊就诊的患者占急诊总数的比率接近30%,如哮喘、慢性阻塞性肺疾病(简称慢阻肺)、急性喉梗阻、急性呼吸道感染、重症肺炎等,一些因非呼吸系统疾病急诊就诊的患者也可伴呼吸道相关症状或并发症;③儿童及老年人占比高;④急危重症、并发症复杂、病史不清、病因不明的

中文标题:

雾化吸入疗法急诊临床应用专家共识

发布日期:

2018-07-30

简要介绍:

为了规范雾化吸入疗法的临床应用,结合急诊急救专业的特殊性:①急症患者发病突然,疾病进展不可预见;②呼吸系统疾病占比高,有统计显示,我国因呼吸系统疾病急诊就诊的患者占急诊总数的比率接近30%,如哮喘、慢性阻塞性肺疾病(简称慢阻肺)、急性喉梗阻、急性呼吸道感染、重症肺炎等,一些因非呼吸系统疾病急诊就诊的患者也可伴呼吸道相关症状或并发症;③儿童及老年人占比高;④急危重症、并发症复杂、病史不清、病因不明的患者占比高;⑤雾化吸入疗法在我国急诊中应用尚不规范,使用率远低于临床要求。中国医师协会急诊医师分会、中国人民解放军急救专业委员会和北京急诊医学学会邀请全国急诊急救领域专家经多次协商、讨论,共同制定了《雾化吸入疗法急诊临床应用专家共识(2018)》,希望能为一线急诊医护人员提供理论与实践指导,进一步提高雾化吸入疗法在急诊的应用水平,以使更多患者获益。 

拓展指南:急诊相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=雾化吸入疗法急诊临床应用专家共识)] GetToolGuiderByIdResponse(projectId=1, id=67cae1c00162536a, title=雾化吸入疗法急诊临床应用专家共识, enTitle=, guiderFrom=中国急救医学.2018.38(7):565-574., authorId=null, author=, summary=为了规范雾化吸入疗法的临床应用,结合急诊急救专业的特殊性:①急症患者发病突然,疾病进展不可预见;②呼吸系统疾病占比高,有统计显示,我国因呼吸系统疾病急诊就诊的患者占急诊总数的比率接近30%,如哮喘、慢性阻塞性肺疾病(简称慢阻肺)、急性喉梗阻、急性呼吸道感染、重症肺炎等,一些因非呼吸系统疾病急诊就诊的患者也可伴呼吸道相关症状或并发症;③儿童及老年人占比高;④急危重症、并发症复杂、病史不清、病因不明的, cover=, journalId=null, articlesId=null, associationId=327, associationName=中国医师协会急诊医师分会, associationIntro=急诊科医师分会成立将推动急诊发展,为抢救患者生命,维护人民健康做出更大贡献,分会将就急诊科自身建设、行业发展、自律维权、科研合作、文化建设等问题展开工作,把分会建成为急诊科医师温馨家园!, copyright=0, guiderPublishedTime=Mon Jul 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>为了规范雾化吸入疗法的临床应用,结合急诊急救专业的特殊性:①急症患者发病突然,疾病进展不可预见;②呼吸系统疾病占比高,有统计显示,我国因呼吸系统疾病急诊就诊的患者占急诊总数的比率接近30%,如哮喘、慢性阻塞性肺疾病(简称慢阻肺)、急性喉梗阻、急性呼吸道感染、重症肺炎等,一些因非呼吸系统疾病急诊就诊的患者也可伴呼吸道相关症状或并发症;③儿童及老年人占比高;④急危重症、并发症复杂、病史不清、病因不明的患者占比高;⑤雾化吸入疗法在我国急诊中应用尚不规范,使用率远低于临床要求。中国医师协会急诊医师分会、中国人民解放军急救专业委员会和北京急诊医学学会邀请全国急诊急救领域专家经多次协商、讨论,共同制定了《雾化吸入疗法急诊临床应用专家共识(2018)》,希望能为一线急诊医护人员提供理论与实践指导,进一步提高雾化吸入疗法在急诊的应用水平,以使更多患者获益。 </div> <div><br> </div> 拓展指南:<strong>与<font color=red>急诊</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=0ee0e1c00160851a" title="急性缺血性脑卒中急诊急救中国专家共识(2018)" target=_blank>急性缺血性脑卒中急诊急救中国专家共识(2018)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=916f41c001600879" title="急诊预检分诊专家共识" target=_blank>急诊预检分诊专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=656511c001583af3" title="2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防" target=_blank>2018 ESGCD指南:急诊医疗中艰难梭菌感染的预防</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=84cff1c0015e86dc" title="急诊氧气治疗专家共识" target=_blank>急诊氧气治疗专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=cd7ce1c0015e2945" title="中国急性缺血性脑卒中中西医急诊诊治专家共识" target=_blank>中国急性缺血性脑卒中中西医急诊诊治专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%80%A5%E8%AF%8A" target=_blank>有关急诊更多指南</a></ul>, tagList=[TagDto(tagId=78946, tagName=雾化吸入疗法), TagDto(tagId=78947, tagName=急诊临床应用)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9492, appHits=502, showAppHits=12, pcHits=4802, showPcHits=5207, likes=147, shares=33, comments=9, approvalStatus=1, publishedTime=Fri Aug 10 00:48:21 CST 2018, publishedTimeString=2018-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 10 00:48:21 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:11:45 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=雾化吸入疗法急诊临床应用专家共识)])
雾化吸入疗法急诊临床应用专家共识
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192762, encodeId=b8a21192e62ec, content=非常好,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:39:15 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192529, encodeId=29ec119252975, content=实用,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:34:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339894, encodeId=fe80339894b7, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 21 10:28:45 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338294, encodeId=cfd333829495, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 13 07:58:50 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337664, encodeId=18cc33e664da, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Aug 10 07:27:07 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2022-02-12 ms3000000637975859

    非常好,很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192762, encodeId=b8a21192e62ec, content=非常好,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:39:15 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192529, encodeId=29ec119252975, content=实用,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:34:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339894, encodeId=fe80339894b7, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 21 10:28:45 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338294, encodeId=cfd333829495, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 13 07:58:50 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337664, encodeId=18cc33e664da, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Aug 10 07:27:07 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2022-02-11 ms3000000637975859

    实用,非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192762, encodeId=b8a21192e62ec, content=非常好,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:39:15 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192529, encodeId=29ec119252975, content=实用,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:34:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339894, encodeId=fe80339894b7, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 21 10:28:45 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338294, encodeId=cfd333829495, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 13 07:58:50 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337664, encodeId=18cc33e664da, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Aug 10 07:27:07 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2018-08-21 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1192762, encodeId=b8a21192e62ec, content=非常好,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:39:15 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192529, encodeId=29ec119252975, content=实用,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:34:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339894, encodeId=fe80339894b7, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 21 10:28:45 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338294, encodeId=cfd333829495, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 13 07:58:50 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337664, encodeId=18cc33e664da, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Aug 10 07:27:07 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2018-08-13 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1192762, encodeId=b8a21192e62ec, content=非常好,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sat Feb 12 20:39:15 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192529, encodeId=29ec119252975, content=实用,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:34:56 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=339894, encodeId=fe80339894b7, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 21 10:28:45 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338294, encodeId=cfd333829495, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Aug 13 07:58:50 CST 2018, time=2018-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337664, encodeId=18cc33e664da, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Fri Aug 10 07:27:07 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2018-08-10 yjs木玉

    学习学习再学习

    0